Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Ervopax Tab 5 D Tablet is a Health Canada–registered human drug (DIN 02098660) held by Homeocan Inc., containing Silicon Dioxide. Health Canada lists its status as Cancelled Post Market (status date 04 Aug 2009). Nexara Health has matched 25 registrations of Silicon Dioxide across 3 other regulated markets, 5 of them in the same strength and dosage form.

Health Canada registration

DIN02098660
Brand nameErvopax Tab
Active ingredientSilicon Dioxide
Strength5 D
Dosage formTablet
RouteOral
CompanyHomeocan Inc.
StatusCancelled Post Market — 04 Aug 2009
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Silicon Dioxide registered in other markets

25 registrations of the same molecule in 3 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United Arab EmiratesCarbowhite TabletsPHARMEX GROUP, LLC, Ukraine, Boryspil-08300,CombinationTabletActiveEDE
United Arab EmiratesCarbowhite TabletsPHARMEX GROUP, LLC, Ukraine, Boryspil-08300,CombinationTabletActiveEDE
United StatesSiliceaHyland's Inc.TabletlistedFDA NDC
United StatesSiliceaHyland's Inc.TabletlistedFDA NDC
United StatesSilicea 6XHyland's Inc.Tablet, SolublelistedFDA NDC
MalaysiaMINESU SILICA 94.5mg / 5ml LIQUIDKiwita Sdn. Bhd.Health SupplementPRODUCT APPROVEDNPRA
United StatesBioMicroneedle PDRN CreamGuangzhou Shengyanghui Industrial Trading Co., LtdCreamlistedFDA NDC
United StatesD-132DNA Labs, Inc.SolutionlistedFDA NDC
United StatesSilica marinaBoironPelletlistedFDA NDC
United StatesSilica MarinaBoironPelletlistedFDA NDC
United StatesSiliceaBoironPelletlistedFDA NDC

See every manufacturer of Silicon Dioxide worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Ervopax Tab (DIN 02098660) marketed in Canada?

No. Health Canada lists DIN 02098660 as Cancelled Post Market as of 04 Aug 2009.

Who holds the Canadian licence for this product?

Homeocan Inc. is the company of record in the Health Canada Drug Product Database.

Is Silicon Dioxide registered outside Canada?

Yes — Nexara Health has matched 25 registrations in 3 other markets, including 5 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02098660, status date 2009-08-04; national medicine registries: EDE, FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02098660, status date 2009-08-04; national medicine registries: EDE, FDA NDC, NPRA.

Health Canada Drug Product Database (DPD), DIN 02098660, status date 2009-08-04; national medicine registries: EDE, FDA NDC, NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.